Article
GDF15 as a potential biomarker to distinguish fibrotic from non-fibrotic hypersensitivity pneumonitis.
Scientific reports - 9 Jan 2024
Alarcon-Dionet A, Ruiz A, Chavez-Galan L, Buendia-Roldan I, Selman M
Abstract excerpt
Hypersensitivity Pneumonitis (HP) is an immune-mediated interstitial lung disease (ILD) characterized by fibrotic HP (fHP) or non-fibrotic HP (non-fHP). Fibrosis is associated with poor prognosis, emphasizing the need for biomarkers to distinguish fHP from non-fHP. This study aimed to determine the plasma levels of GDF15 in HP patients and assess its association with lung function and phenotype classification....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
